Literature DB >> 7581478

Conjugation of carcinogens by theta class glutathione s-transferases: mechanisms and relevance to variations in human risk.

F P Guengerich1, R Thier, M Persmark, J B Taylor, S E Pemble, B Ketterer.   

Abstract

Conjugation of chemicals with glutathione (GSH) can lead to decreased or increased toxicity. A genetic deficiency in the GSH S-transferase mu class gene M1 has been hypothesized to lead to greater risk of lung cancer in smokers. Recently a gene deletion polymorphism involving the human theta enzyme T1 has been described: the enzyme is present in erythrocytes and can be readily assayed. A rat theta class enzyme, 5-5, has structural and catalytic similarity and the protein was expressed in the Salmonella typhimurium tester strain TA1535. Expression of the cDNA vector increased the mutagenicity of ethylene dibromide and several methylene dihalides. Mutations resulting from the known GSH S-transferase substrate 1,2-epoxy-3-(4'nitrophenoxy)propane were decreased in the presence of the transferase. Expression of transferase 5-5 increased mutations when 1,2,3,4-diepoxybutane (butadiene diepoxide), 4-bromo-1,2-epoxybutane, or 1,3-dichloracetone were added. The latter compound is a model for the putative 1,2-dibromo-3-chloropropane oxidation product 1-bromo-3-chloroacetone. These genotoxicity and genotyping assays may be of use in further studies of the roles of GSH S-transferase theta enzymes in bioactivation and detoxication and any changes in risk due to polymorphism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7581478     DOI: 10.1097/00008571-199512001-00010

Source DB:  PubMed          Journal:  Pharmacogenetics        ISSN: 0960-314X


  8 in total

Review 1.  Genetic association studies of antioxidant pathway genes and schizophrenia.

Authors:  Kodavali V Chowdari; Mikhil N Bamne; Vishwajit L Nimgaonkar
Journal:  Antioxid Redox Signal       Date:  2010-11-01       Impact factor: 8.401

2.  Human glutathione S-transferase A1, T1, M1, and P1 polymorphisms and susceptibility to prostate cancer in the Japanese population.

Authors:  Yasuhiro Komiya; Hiromasa Tsukino; Hiroyuki Nakao; Yoshiki Kuroda; Hirohisa Imai; Takahiko Katoh
Journal:  J Cancer Res Clin Oncol       Date:  2004-12-23       Impact factor: 4.553

3.  Glutathione S-transferase mu, omega, pi, and theta class variants and smoking in Parkinson's disease.

Authors:  Angelika D Wahner; Charles E Glatt; Jeff M Bronstein; Beate Ritz
Journal:  Neurosci Lett       Date:  2006-12-27       Impact factor: 3.046

4.  Possible risk modification by CYP1A1, GSTM1 and GSTT1 gene polymorphisms in lung cancer susceptibility in a South Indian population.

Authors:  Leelakumari Sreeja; Vani Syamala; Sreedharan Hariharan; Jayaprakash Madhavan; Sivanandan Choondal Devan; Ravindran Ankathil
Journal:  J Hum Genet       Date:  2005-10-14       Impact factor: 3.172

5.  Association of GSTT1 gene polymorphisms with the risk of prostate cancer: an updating meta-analysis.

Authors:  Jihong Wang; Yuemin Xu; Qiang Fu; Jianjun Yu; Zhong Chen; Zhangshun Liu; Chao Li; Hui Guo; Mingkai Xie
Journal:  Tumour Biol       Date:  2013-03-02

6.  Increased bioactivation of dihaloalkanes in rat liver due to induction of class theta glutathione S-transferase T1-1.

Authors:  P J Sherratt; M M Manson; A M Thomson; E A Hissink; G E Neal; P J van Bladeren; T Green; J D Hayes
Journal:  Biochem J       Date:  1998-11-01       Impact factor: 3.857

7.  An open label pilot study to evaluate the efficacy of Spanish black radish on the induction of phase I and phase II enzymes in healthy male subjects.

Authors:  Malkanthi Evans; Elaine Paterson; David M Barnes
Journal:  BMC Complement Altern Med       Date:  2014-12-09       Impact factor: 3.659

8.  Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of non-small cell lung cancer in Andhra Pradesh region of South India.

Authors:  Vidyullatha Peddireddy; Siva Prasad Badabagni; Sandhya Devi Gundimeda; Vasudha Mamidipudi; Pardhanandana Reddy Penagaluru; Hema Prasad Mundluru
Journal:  Eur J Med Res       Date:  2016-04-18       Impact factor: 2.175

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.